Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.650
+0.010 (0.27%)
At close: Dec 20, 2024, 4:00 PM
3.670
+0.020 (0.55%)
After-hours: Dec 20, 2024, 4:54 PM EST
Aquestive Therapeutics Employees
Aquestive Therapeutics had 135 employees as of December 31, 2023. The number of employees increased by 5 or 3.85% compared to the previous year.
Employees
135
Change (1Y)
5
Growth (1Y)
3.85%
Revenue / Employee
$436,296
Profits / Employee
-$260,689
Market Cap
332.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Valneva SE | 676 |
Spok Holdings | 384 |
NeuroPace | 171 |
Absci | 155 |
Acelyrin | 135 |
Olema Pharmaceuticals | 74 |
Design Therapeutics | 58 |
Candel Therapeutics | 42 |
AQST News
- 6 weeks ago - Undercovered Dozen: Asbury Automotive, Globalstar, Northland Power, Aquestive Therapeutics + - Seeking Alpha
- 6 weeks ago - Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Aquestive: Rare Opportunity With Dual Platform Strategy - Seeking Alpha
- 6 weeks ago - Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day - GlobeNewsWire
- 3 months ago - Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th - GlobeNewsWire
- 4 months ago - Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings - Seeking Alpha
- 4 months ago - Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire